Financhill
Back

Fossil Group Vs. Akero Therapeutics Industry Stock Comparison

Sell
37

FOSL
Fossil Group

Last Price:
0.79
Seasonality Move:
7.56%
Sell
34

AKRO
Akero Therapeutics

Last Price:
20.59
Seasonality Move:
19.37%
Sell
37
Fossil Group (FOSL) is a Sell

Is Fossil Group a Buy, Sell or Hold?

  • The current Fossil Group [FOSL] share price is $0.78. The Score for FOSL is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • FOSL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Akero Therapeutics (AKRO) is a Sell

Is Akero Therapeutics a Buy, Sell or Hold?

  • The current Akero Therapeutics [AKRO] share price is $21.60. The Score for AKRO is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • AKRO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FOSL Stock Price Chart

What is Fossil Group's stock price today?

  • The Fossil Group share price today is $0.78
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FOSL is experiencing slight selling pressure.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

  • The Akero Therapeutics share price today is $21.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing selling pressure, which indicates risk of future bearish movement.

FOSL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 33.77 Sell
Chaikin Money Flow: -317072 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.86 - 1) Sell
Bollinger Bands (100): (0.94 - 1.34) Sell

AKRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.04 Sell
Relative Strength Index (14 RSI): 35.56 Sell
Chaikin Money Flow: -737167 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.29 - 26.09) Sell
Bollinger Bands (100): (19.48 - 26.18) Sell

FOSL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.9 Sell
20-day SMA: 0.94 Sell
50-day SMA: 0.98 Sell
200-day SMA: 1.6 Sell
8-day EMA: 0.87 Sell
20-day EMA: 0.92 Sell
50-day EMA: 1 Sell
200-day EMA: 1.69 Sell

AKRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 22.25 Sell
20-day SMA: 23.46 Sell
50-day SMA: 24.5 Sell
200-day SMA: 29.68 Sell
8-day EMA: 22.22 Sell
20-day EMA: 23.37 Sell
50-day EMA: 24 Sell
200-day EMA: 27.96 Sell

Fossil Group Earnings Growth & FOSL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.36 per share, a decrease next quarter of $0.16 per share, a decrease this year of $1.11 per share, and a decrease next year of $0.63 per share.

Fossil Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Akero Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):